Hartmann + Glucose Viaflo (Potassium Chloride, Sodium Chloride, Calcium Chloride Dihydrate, Glucose, Sodium Lactate)

Hartmann + Glucose Viaflo is indicated for clinical situations that require rapid restoration of intravascular volume and electrolyte balance.

• Fluid replacement in patients with hypovolemia or dehydration.
• Electrolyte replenishment after significant fluid loss (e.g., burns, diarrhea, vomiting).
• Support of postoperative patients to maintain circulating volume.
• Management of patients receiving parenteral nutrition who need additional glucose and electrolytes.
• Treatment of metabolic acidosis when combined with appropriate clinical measures.

Adverse reactions to Hartmann + Glucose Viaflo are generally infrequent, but they can occur with any intravenous therapy.

Common

• Mild local irritation at the infusion site.
• Transient nausea or vomiting.
• Slight increase in serum potassium or sodium levels.
• Temporary hyperglycemia in susceptible individuals.

Serious

• Severe electrolyte imbalance (hyperkalemia, hypernatremia) leading to cardiac arrhythmia.
• Anaphylactic or severe allergic reaction.
• Fluid overload causing pulmonary edema.

Clinicians should evaluate patient-specific factors before administering Hartmann + Glucose Viaflo to minimize risks.

• Assess baseline electrolyte and glucose levels; adjust infusion rate accordingly.
• Use caution in patients with renal or cardiac impairment due to risk of fluid overload.
• Avoid rapid infusion in neonates or patients with compromised vascular integrity.
• Monitor for signs of hyperkalemia, especially in those receiving potassium‑sparing medications.
• Do not administer to patients with known hypersensitivity to any component of the solution.
• Consider alternative fluids for patients with severe metabolic acidosis not corrected by lactate.

Hartmann + Glucose Viaflo may interact with other medications that affect electrolyte balance, glucose metabolism, or fluid status.

Avoid

• Concurrent high‑dose potassium supplements or potassium‑sparing diuretics, which can precipitate hyperkalemia.
• Large volumes of other sodium‑rich IV fluids that may cause hypernatremia.
• Intravenous insulin administered without glucose monitoring, increasing risk of hypoglycemia.

Use with caution

• Loop or thiazide diuretics, requiring close monitoring of electrolyte shifts.
• Calcium channel blockers, as rapid changes in calcium levels may affect cardiac conduction.
• Blood transfusions, because combined fluid loads can lead to volume overload.
• Medications that alter lactate metabolism, such as metformin, necessitating careful acid‑base assessment.